Dr. Izet M. Kapetanovic, PhD, is a pharmacologist/toxicologist with over 25 years of experience in drug discovery and development, life sciences, conducting and managing laboratory research and translational research programs, and administering and managing research programs and contracts. He has been personally involved in the drug development process from early laboratory discovery, screening, and mechanism studies, to early clinical studies. He has published extensively in major peer reviewed scientific journals, made numerous presentations at major scientific meetings, and serves frequently as a reviewer for journals in these areas, as well as journal editorial boards. He is actively involved in different aspects and disciplines of drug development. Additionally, he effectively interacts with different groups in the process, including having coordinated collaborative metabolism and toxicity projects involving NIH, FDA, academia, and pharmaceutical industry. Presently, he is actively involved in the preclinical drug development of cancer chemopreventive drugs, including the translational PREVENT Program.